
|Articles|October 15, 2012
Risky business: Rx drugs obtained in the secondary market
Trying to save on Rx drugs from the secondary market can land you in hot water with Uncle Sam.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
4
Pharmacists Want Prescribing Authority With Proper Training, Support
5






























